Gyre Therapeutics (GYRE) Short term Debt (2010 - 2014)
Gyre Therapeutics (GYRE) recorded Short term Debt of $478,000 in Q3 2014, down 45.2% from $873,000 a year earlier and down 31.6% from the prior quarter.
Powered by 
Analysis
Gyre Therapeutics (GYRE) Short term Debt (2010 - 2014) Analysis & Trends
At the end of FY2013, Gyre Therapeutics reported Short term Debt of $853,000, up 0.2% from FY2012.
- Annual Short term Debt has a three-year compound annual growth rate of -20.7% (FY2010 to FY2013).
- Across earlier years, Short term Debt came in at $851,000 in FY2012 (-31.4%), $1.24 million in FY2011 (-27.4%) and $1.71 million in FY2010.
- The Q3 2014 figure is the lowest quarterly Short term Debt in data going back to Q4 2010.
- On a year-over-year basis, Short term Debt has declined for three consecutive quarters, with an average decline of 13.3% over the last eight quarters.
- Peak year-over-year performance for Short term Debt in the last five years was growth of 3.4% in Q3 2013, against a decline of 54.5% in Q2 2012 at the low end.
- Per Business Quant, the preceding three quarters came in at $699,000 (Q2 2014), $776,000 (Q1 2014) and $853,000 (Q4 2013).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Gyre Therapeutics | 777.23 Mn | 579.94 Mn | 26.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2014 | 478,000.00 |
| Jun 30, 2014 | 699,000.00 |
| Mar 31, 2014 | 776,000.00 |
| Dec 31, 2013 | 853,000.00 |
| Sep 30, 2013 | 873,000.00 |
| Jun 30, 2013 | 866,000.00 |
| Mar 31, 2013 | 858,000.00 |
| Dec 31, 2012 | 851,000.00 |
| Sep 30, 2012 | 844,000.00 |
| Jun 30, 2012 | 870,000.00 |
| Mar 31, 2012 | 896,000.00 |
| Dec 31, 2011 | 1.24 Mn |
| Sep 30, 2011 | 1.59 Mn |
| Jun 30, 2011 | 1.91 Mn |
| Dec 31, 2010 | 1.71 Mn |
API Access
Gyre Therapeutics Short term Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-debt&ticker=GYRE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-debt", "ticker": "GYRE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=short-term-debt&ticker=GYRE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();